Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02770391
Title ARN-509 and Leuprolide in Intermediate and High-risk Prostate Cancer
Recruitment Completed
Gender male
Phase Phase II
Variant Requirements No
Sponsors Case Comprehensive Cancer Center
Age Groups: adult
Covered Countries USA

No variant requirements are available.